Kura Oncology to Host Virtual Investor and Analyst Events on Farnesyl Transferase Inhibitor Program - Candlesense

KURA Clinical trials

Kura Oncology to Host Virtual Investor and Analyst Events on Farnesyl Transferase Inhibitor Program

Published September 03, 2025 at 12:02 PM

(NASDAQ:KURA) September 16 event to highlight preclinical data on the combination of FTI agents with multiple classes of targeted therapies